TruthArchive.ai - Related Video Feed

Digital certificates are needed for people working in nursing homes, hospitals, and schools to authenticate their vaccination status. Travel may also require such authentication. Pfizer broke every record in developing the vaccine.

Israel was the first to emerge from COVID by using its advanced medical database to analyze the effects of Pfizer's vaccines on different health conditions. This database, covering 98% of the population, allowed for quick and efficient monitoring. Israel's collaboration with Pfizer turned the country into a testing ground, providing valuable data to the world.

The Prime Minister of Israel discusses the country's progress in vaccinating its population against COVID-19. Currently, 82% of people above 60 years old have been vaccinated, but the goal is to reach 95%. The challenge lies in the race between vaccination and mutation, particularly with the British mutation and potential future mutations. Israel aims to vaccinate the high-risk groups first and then the rest of the population. The Prime Minister expects vaccine companies to modify their vaccines to address new mutations. Israel's success in vaccination is attributed to quick and decisive action, including purchasing vaccines without hesitation and personal leadership involvement. The country's efficient distribution system, facilitated by four competing and cooperating HMOs, has allowed it to serve as a laboratory for achieving herd immunity.

I also think this this issue to do with the technology and the digital infrastructure, I just want to emphasize how important I think that is. Because in the end, you you you you need the data. You need to know who's been vaccinated and who hasn't. Some of the vaccines that will come on down the line will be multiple there'll be multiple shots. So you've got to have the the reasons to do with the health care more generally, but certainly for a pandemic or for vaccines, for you've got to have a proper digital infrastructure, and many countries don't have that. In fact, most countries don't have that.

Speaker 0 emphasizes the importance of technology and the digital infrastructure. "This issue to do with the technology and the digital infrastructure, I just want to emphasize how important I think that is." Because in the end, "you you you you need the data. You need to know who's been vaccinated and who hasn't." "Some of the vaccines that will come on down the line will be multiple there'll be multiple shots." So you've got to have the the reasons to do with the health care more generally, but certainly for a a pandemic or for vaccines, you've got to have a proper digital infrastructure," He says. "and many countries don't have that." "In fact, most countries don't have that."

Israel has vaccinated 82% of people over 16 and aims for 95%. The challenge is the race between vaccination and mutations. Israel's success is due to quick vaccine purchases and personal leadership. The country can serve as a global example for achieving herd immunity.

The speaker lists individuals in leadership positions at the CDC, Pfizer, Moderna, BlackRock, and Johnson & Johnson, claiming they are Jewish and have dual citizenship with Israel. These individuals include Rochelle Walensky (Director of the CDC), Anne Shewelczy (Deputy Director of the CDC), Sherry Berger (CDC Chief Of Staff), Mitchell Wolf (CDC Chief Medical Officer), Jeff Resick (Director of the CDC of the Washington office), Jeff Zainz (COVID star), Andy Slabbitt (COVID Senior Advisor), Rachel Levine (Assistant Of Health Secretary For Human Services), Albert (Head of Pfizer vaccines), Michael Dost (Pfizer Chief Scientist), calls x (Moderna Chief Scientist), Larry Fink (BlackRock CEO), Rob Kapital (BlackRock president), and Wall Stryker (Chief Medical Officer of Johnson and Johnson). The speaker suggests this is pertinent to the topic of COVID.

The speaker emphasizes the importance of technology and digital infrastructure in managing vaccinations. They highlight the need for data on who has been vaccinated and who hasn't, especially considering future vaccines may require multiple shots. A proper digital infrastructure is crucial for healthcare in general and particularly during a pandemic. However, the speaker notes that most countries lack this infrastructure.

During the discussion about COVID, the speaker lists several individuals in leadership positions at the CDC and pharmaceutical companies, mentioning their dual citizenship with Israel and their Jewish background. The speaker also mentions the chair's request to stop speaking and comments on Israel's stability. The names of individuals and their affiliations are mentioned, including Pfizer, Moderna, and BlackRock. The speaker expresses appreciation for someone's patience and love. The transcript ends with a request to stop speaking.

In the video, the speaker talks about how Israel was able to come out of COVID first. They mention a book called "My Conversations With Albert Bourla of Pfizer" where they convinced him to give Israel the necessary vaccines. Israel's advantage was their extensive medical database, with 98% of the population having digitized medical records. This allowed them to analyze the vaccines' effects on different conditions, such as meningitis and high blood pressure, on a statistical level. Israel became a testing ground for Pfizer, and the information they gathered was shared with the world through medical publications.

That extraordinary person is Pfizer Chairman and CEO, Doctor. Albert Borla. Doctor Borla led his team to deliver a COVID nineteen vaccine in record time while taking a risk by declining US federal funding to avoid government bureaucracy and expedite vaccine production. A child of Holocaust survivors from a Greek Jewish community destroyed by the Nazis, he's proud of his Jewish heritage, is active in Holocaust remembrance and education, and a strong supporter of Israel, which was the first country outside The US to receive the Pfizer vaccine and the antiviral pill. With more than two and a half billion Pfizer vaccine doses already distributed. Because of Doctor. Borla's extraordinary contribution to humanity as the world battles the worst health crisis in January, Doctor Albert Borla has been selected as the recipient of the 2022 Genesis Prize, the Jewish Nobel Prize. Thank you, and congratulations, Doctor. Borla.

I spoke with Pfizer's CEO, Albert Bourla, about the approval process. We discussed vaccine safety and serious side effects. Many companies and institutions are embracing the COVID vaccine due to its effectiveness. Logistics are crucial in this process. Translation (if needed): I talked to Pfizer's CEO, Albert Bourla, about the approval process. We talked about vaccine safety and serious side effects. Many companies and institutions are adopting the COVID vaccine because it works well. Logistics are important in this situation.

In this video, the speaker discusses how Israel was able to come out of COVID first by using their extensive medical database. They persuaded Pfizer to provide vaccines by utilizing their 98% digitized medical records. Israel became a testing ground for Pfizer's vaccines, and the information was shared with the world. The speaker also mentions their plan to create a genetic database by collecting saliva samples from the population. They believe this database can be used by pharmaceutical and medical companies to develop groundbreaking technologies. The speaker emphasizes the potential benefits not only for Israel but also for their neighbors in the Middle East and the world.

We negotiated with Pfizer for a deal to efficiently vaccinate a large portion of the Israeli population. We assured Pfizer that we would not share personal data but would monitor the vaccine's impact on disease levels, economy, and social life. We will track any effects on specific groups, like those with heart conditions, while respecting privacy.

The speaker emphasizes the importance of technology and digital infrastructure for managing vaccines and future pandemics. They highlight the need for data on vaccinations and the necessity of a proper digital infrastructure, which many countries lack. The speaker suggests that the G20 should focus on creating partnerships and mechanisms for handling future pandemics effectively. They mention the role of formal institutions like the WTO and organizations without bureaucracy and politics. The speaker concludes by stating that politicians will prioritize a plan if they see its relevance in the near future.

Speaker 0: Calvin will receive one shot. We are leading in global vaccination efforts with over 1.1 billion shots administered. We will continue our efforts and have provided significant funding to ensure everyone can be vaccinated. It is crucial for us to play the largest role in vaccinating the world.

Speaker 0: My goal is to protect Israel and ensure its future. I want to be remembered as its protector. Speaker 1: Welcome, Mr. Prime Minister. Speaker 0: Thank you. Speaker 1: We convinced Pfizer that they could benefit from our data, and our health system distributed it efficiently through our digital system. I spoke with Pfizer's CEO 21 times, not 70. I also spoke with other company heads. Personal leadership is crucial in ensuring vaccine stock and distribution. Israel can serve as a global test case to understand the efficacy of vaccination in reopening economies. We are taking calculated risks to move forward and many countries can learn from us.

In the global fight against COVID-19, the Jewish people have had an outsized impact. As scientists, chief medical officers, and top healthcare officials, their contributions have been invaluable. However, one person stands above the rest: Pfizer Chairman and CEO, Dr. Albert Borla. I led my team to deliver a COVID-19 vaccine in record time, declining US federal funding to avoid bureaucracy and expedite production. As a child of Holocaust survivors, I am proud of my Jewish heritage and a strong supporter of Israel, the first country outside the US to receive the Pfizer vaccine and antiviral pill. The world is better off with my leadership in saving lives. With over 2.5 billion Pfizer vaccine doses distributed, I am honored to be selected as the recipient of the 2022 Genesis Prize, the Jewish Nobel Prize, for my contribution to humanity during the worst health crisis in a century.

Israel was able to come out of COVID first by using its extensive medical database, which includes digitized medical records for 98% of the population. This allowed them to analyze the effects of vaccines on different medical conditions. Israel became a testing ground for Pfizer, and the information gathered was shared with the world. The plan now is to expand the database to include genetic records from the entire population, creating a powerful resource for medical and biotechnological advancements. Israel aims to prioritize Israeli firms initially, but ultimately hopes to benefit the Middle East and the world with groundbreaking technologies.

A proper digital infrastructure is critical for managing vaccinations, especially with multiple-shot vaccines. It's essential to track who has been vaccinated. This is important not only for healthcare in general, but specifically for managing pandemics and vaccine distribution. However, most countries currently lack this necessary digital infrastructure.

Israel's success in vaccinating its population against COVID-19 was due to its extensive medical database, which contains digitized records for 98% of the population. This allowed the country to provide Pfizer with valuable data on the vaccine's effects on different medical conditions. The government plans to expand this database to include genetic information from saliva samples, creating a powerful resource for medical and biotechnological research. Israeli firms will be given preference initially, but the goal is to foster a groundbreaking biotechnological industry that can benefit the world. Israel aims to become a beacon of innovation and a leader in healthcare advancements.

Israel emerged from COVID-19 by leveraging its extensive medical database, which includes digitized records for 98% of the population. This allowed for effective collaboration with Pfizer to assess vaccine impacts on various health conditions. The data was shared globally, contributing to medical knowledge. Plans are in place to expand this database by incorporating genetic information through voluntary saliva samples, creating a robust resource for research. This diverse genetic and medical database will enable pharmaceutical and medical companies to develop innovative biotechnological solutions. Initially, Israeli firms will have priority access, fostering a groundbreaking industry that can benefit not only Israel but also neighboring countries and the world.

You need personal leadership to make a difference. Israel could be a global example for achieving herd immunity.

The speaker lists individuals in charge of the CDC, Pfizer, Moderna, BlackRock, and Johnson & Johnson, stating their dual citizenship with Israel and religion as Jewish. The speaker names Rochelle Walensky, Anne Shoalje, Sherry Berger, Mitchell Wolf, Jeff Rezzik, Jeff Zanes, Andy Slavitt, and Rachel Levine as holding positions in the CDC. Albert Bourla and Michael Dolsten are identified as being with Pfizer, and Paul Zaks with Moderna. Larry Fink and Rob Kapito are named as being with BlackRock, and Walt Schreiner and Michael Rosenwald with Johnson & Johnson.

Israel was the first to emerge from COVID by using its advanced medical database to analyze the effects of vaccines on different health conditions. By partnering with Pfizer, Israel became a testing ground for vaccine efficacy. The data collected was shared globally through medical publications.